ACTU — ACTUATE THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -0.14 | — | -0.07 | -0.20 | 2 | +1 |
| Mar 2027 | -0.13 | — | -0.06 | -0.19 | 2 | +1 |
| Jun 2027 | -0.12 | — | -0.06 | -0.18 | 2 | +1 |
| Sep 2027 | -0.10 | — | -0.05 | -0.16 | 2 | +1 |
| Dec 2027 | -0.09 | — | -0.05 | -0.13 | 2 | +1 |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -0.71 | — | -0.57 | -0.85 | 2 | +1 |
| Dec 2027 | -0.44 | — | -0.22 | -0.66 | 2 | +1 |
| Dec 2028 | -0.39 | — | -0.25 | -0.53 | 2 | +1 |
| Dec 2029 | 0.32 | 0.8× | 0.60 | 0.04 | 2 | −1 |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 42 SEC-registered investment managers reported holding ACTU (ACTUATE THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $7.84B across 13.39M shares. That is +1.1% by share count (+150.20K shares) versus the previous quarter, while reported value moved +38789.5%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 4 opened new positions, 5 added to existing stakes, 15 trimmed, 29 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of ACTUATE THERAPEUTICS INC (ACTU) include BIOS Capital Management, LP, Vanguard Group, Voss Capital, LP, ranked by reported 13F value among the 105 institutional holders on this page.
ACTU is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 42 | 13.39M | $7.84B | +0.8% |
| Q2 2026 | 66 | 13.83M | $21.16M | -2.7% |
| Q1 2026 | 63 | 13.90M | $38.07M | +4.0% |
| Q4 2025 | 45 | 13.13M | $80.38M | +7.7% |
| Q3 2025 | 43 | 12.04M | $80.55M | +7.3% |
| Q2 2025 | 39 | 11.23M | $68.63M | +7.7% |
| Q1 2025 | 26 | 10.41M | $70.53M | +1.3% |
| Q4 2024 | 19 | 10.12M | $80.52M | -40.3% |
Over the 8 quarters shown, institutional share counts increased 32% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (-40.3%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.05M | $7.84B | 22.94% | Hold | |
| 1.90M | $1.48M | 0.11% | Add | |
| 393.43K | $306.88K | 0.00% | Hold | |
| 104.31K | $81.33K | 0.00% | Reduce | |
| 102.61K | $80.01K | 0.00% | Hold | |
| 100.00K | $77.97K | 0.03% | Hold | |
| 90.19K | $70.33K | 0.00% | Reduce | |
| 90.19K | $70.33K | 0.00% | Reduce | |
| 73.19K | $57.06K | 0.03% | Hold | |
| 66.94K | $52.20K | 0.00% | Reduce | |
| 54.50K | $42.51K | 0.00% | Hold | |
| 50.00K | $38.98K | 0.00% | Add | |
| 50.00K | $38.98K | 0.00% | Add | |
| 36.43K | $28.40K | 0.00% | Hold | |
| 25.08K | $19.55K | 0.00% | Reduce | |
| 23.11K | $18.02K | 0.00% | New | |
| 23.11K | $18.02K | 0.00% | Reduce | |
| 21.85K | $17.04K | 0.00% | Reduce | |
| 21.22K | $16.55K | 0.00% | Hold | |
| 19.03K | $14.84K | 0.00% | Hold | |
| 18.52K | $14.44K | 0.00% | Hold | |
| 6.15K | $9.71K | 0.00% | New | |
| 11.91K | $9.29K | 0.00% | Hold | |
| 10.97K | $8.55K | 0.00% | Hold | |
| 10.00K | $7.80K | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.05M | $15.38M | 36.90% | Hold | |
| 1.73M | $2.64M | 0.18% | Hold | |
| 393.43K | $601.95K | 0.00% | Reduce | |
| 127.49K | $195.06K | 0.00% | Add | |
| 127.49K | $195.06K | 0.00% | Add | |
| 112.55K | $172.21K | 0.00% | New | |
| 112.55K | $172.21K | 0.00% | Reduce | |
| 102.61K | $157.00K | 0.01% | Add | |
| 100.00K | $153.00K | 0.05% | Hold | |
| 96.68K | $147.93K | 0.00% | New | |
| 96.68K | $147.93K | 0.00% | New | |
| 90.03K | $137.75K | 0.00% | Reduce | |
| 73.19K | $111.97K | 0.07% | Add | |
| 73.19K | $111.97K | 0.07% | New | |
| 54.50K | $83.38K | 0.00% | Reduce | |
| 39.26K | $60.07K | 0.01% | Hold | |
| 39.13K | $59.87K | 0.00% | New | |
| 36.46K | $55.78K | 0.00% | New | |
| 35.50K | $54.31K | 0.00% | Add | |
| 33.00K | $50.49K | 0.00% | Hold | |
| 28.18K | $43.12K | 0.00% | New | |
| 23.48K | $35.93K | 0.00% | Reduce | |
| 21.22K | $32.47K | 0.00% | Reduce | |
| 21.08K | $32.26K | 0.00% | New | |
| 19.03K | $29.11K | 0.00% | Hold |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.05M | $27.54M | 52.09% | Hold | |
| 1.73M | $4.73M | 0.34% | Add | |
| 427.15K | $1.17M | 0.00% | Reduce | |
| 400.53K | $1.10M | 0.00% | New | |
| 228.33K | $625.63K | 0.00% | Add | |
| 113.27K | $310.35K | 0.26% | New | |
| 100.00K | $274.00K | 0.12% | New | |
| 97.85K | $268.11K | 0.00% | Reduce | |
| 94.59K | $259.18K | 0.01% | Hold | |
| 66.03K | $180.92K | 0.00% | Add | |
| 62.59K | $171.50K | 0.00% | New | |
| 55.54K | $152.17K | 0.00% | New | |
| 50.00K | $137.00K | 0.10% | Add | |
| 39.26K | $107.58K | 0.01% | Add | |
| 36.40K | $99.73K | 0.00% | Add | |
| 33.00K | $90.42K | 0.01% | Add | |
| 31.40K | $86.03K | 0.00% | Add | |
| 30.98K | $84.89K | 0.00% | Hold | |
| 27.11K | $74.28K | 0.00% | New | |
| 27.11K | $74.28K | 0.00% | New | |
| 22.23K | $61.00K | 0.00% | Reduce | |
| 19.03K | $52.14K | 0.01% | Hold | |
| 15.42K | $42.24K | 0.00% | Add | |
| 15.12K | $41.42K | 0.00% | New | |
| 12.96K | $35.52K | 0.00% | Hold |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.05M | $61.51M | 74.44% | Hold | |
| 1.30M | $7.96M | 0.48% | Add | |
| 529.11K | $3.24M | 0.00% | Add | |
| 432.04K | $2.64M | 0.00% | Add | |
| 207.74K | $1.27M | 0.00% | Add | |
| 101.42K | $620.71K | 0.00% | Add | |
| 94.59K | $578.90K | 0.03% | New | |
| 56.29K | $344.50K | 0.00% | Add | |
| 35.26K | $215.00K | 0.00% | Add | |
| 30.98K | $189.61K | 0.00% | New | |
| 23.84K | $145.91K | 0.00% | Add | |
| 23.84K | $145.91K | 0.00% | Add | |
| 21.76K | $133.16K | 0.01% | New | |
| 20.15K | $123.29K | 0.00% | Add | |
| 20.00K | $122.40K | 0.01% | Add | |
| 19.03K | $116.45K | 0.01% | Hold | |
| 18.52K | $113.33K | 0.00% | Reduce | |
| 16.62K | $101.75K | 0.00% | New | |
| 14.95K | $91.47K | 0.00% | Add | |
| 13.12K | $80.29K | 0.00% | Add | |
| 12.96K | $79.35K | 0.00% | Reduce | |
| 12.56K | $76.90K | 0.00% | New | |
| 10.25K | $62.75K | 0.00% | New | |
| 9.53K | $58.34K | 0.00% | Add | |
| 9.31K | $56.97K | 0.00% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.05M | $67.23M | 75.62% | Add | |
| 896.28K | $6.00M | 0.36% | Add | |
| 316.01K | $2.11M | 0.00% | Add | |
| 282.07K | $1.89M | 0.00% | Add | |
| 145.41K | $972.80K | 0.00% | Add | |
| 85.45K | $571.69K | 0.00% | Hold | |
| 49.90K | $333.80K | 0.00% | Add | |
| 19.30K | $129.12K | 0.00% | Add | |
| 19.03K | $127.30K | 0.01% | Hold | |
| 17.00K | $113.73K | 0.01% | Add | |
| 16.21K | $108.48K | 0.00% | Reduce | |
| 14.77K | $98.78K | 0.00% | Hold | |
| 14.77K | $98.78K | 0.00% | Hold | |
| 13.54K | $90.60K | 0.00% | Add | |
| 12.95K | $86.00K | 0.00% | Add | |
| 10.00K | $66.90K | 0.00% | Hold | |
| 8.93K | $59.72K | 0.00% | Add | |
| 8.87K | $59.31K | 0.00% | Reduce | |
| 8.77K | $58.65K | 0.00% | Reduce | |
| 7.63K | $51.02K | 0.00% | Reduce | |
| 6.49K | $43.41K | 0.08% | Reduce | |
| 6.25K | $41.81K | 0.00% | Hold | |
| 6.20K | $41.48K | 0.00% | Reduce | |
| 5.00K | $33.45K | 0.00% | New | |
| 4.87K | $32.59K | 0.00% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.97M | $60.89M | 83.89% | Add | |
| 286.14K | $1.75M | 0.12% | Add | |
| 264.46K | $1.62M | 0.00% | Add | |
| 195.45K | $1.19M | 0.00% | Add | |
| 118.05K | $721.28K | 0.00% | Add | |
| 85.69K | $523.59K | 0.00% | Add | |
| 37.33K | $228.11K | 0.00% | New | |
| 31.41K | $191.94K | 0.00% | New | |
| 27.78K | $169.72K | 0.30% | Hold | |
| 19.03K | $116.26K | 0.01% | New | |
| 18.70K | $114.29K | 0.00% | New | |
| 18.52K | $113.14K | 0.00% | Add | |
| 17.20K | $105.09K | 0.00% | New | |
| 15.29K | $93.43K | 0.00% | Add | |
| 14.77K | $90.21K | 0.00% | New | |
| 14.77K | $90.21K | 0.00% | New | |
| 14.55K | $88.90K | 0.01% | Add | |
| 12.80K | $78.18K | 0.00% | New | |
| 10.37K | $68.41K | 0.00% | Hold | |
| 10.44K | $63.78K | 0.00% | New | |
| 10.00K | $61.10K | 0.00% | Hold | |
| 9.08K | $55.48K | 0.00% | New | |
| 7.74K | $47.29K | 0.00% | Add | |
| 6.25K | $38.19K | 0.00% | New | |
| 5.24K | $32.03K | 0.00% | New |
New Positions (Q3 2026)
- Empowered Funds, LLC 23.11K sh · $18.02K
- Nuveen, LLC 6.15K sh · $9.71K
- FNY Investment Advisers, LLC 8.28K sh · $6.00K
- Caitong International Asset Management Co., Ltd 1 sh · $1
Fully Exited (vs previous quarter)
- AQR Capital Management sold 127.49K sh · $195.06K
- AQR CAPITAL MANAGEMENT LLC sold 127.49K sh · $195.06K
- GEODE CAPITAL MANAGEMENT, LLC sold 112.55K sh · $172.21K
- ABS Direct Equity Fund LLC sold 73.19K sh · $111.97K
- JANE STREET GROUP, LLC sold 39.13K sh · $59.87K
- Goldman Sachs Group sold 35.50K sh · $54.31K
- Mariner, LLC sold 21.08K sh · $32.26K
- Qube Research & Technologies Ltd sold 15.26K sh · $23.34K
- Virtu Financial LLC sold 14.61K sh · $22.00K
- Apollon Wealth Management, LLC sold 14.01K sh · $21.44K
- IEQ CAPITAL, LLC sold 13.89K sh · $21.25K
- HRT FINANCIAL LP sold 14.03K sh · $21.00K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| BIOS Capital Management, LP | 10.05M | 10.05M | 10.05M | 10.05M | 10.05M | 9.97M | 9.89M | 9.89M | — |
| Voss Capital, LP | 1.90M | 1.73M | 1.73M | 1.30M | 896.28K | 286.14K | 142.38K | 55.25K | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 393.43K | 393.43K | 400.53K | — | — | — | — | — | — |
| Geode Capital Management | 104.31K | 112.55K | 228.33K | 207.74K | 145.41K | 118.05K | 33.49K | 27.89K | 27.89K |
| Texas Capital Bank Wealth Management Services Inc | 102.61K | 102.61K | 94.59K | 94.59K | — | — | — | — | — |
| Palogic Value Management, L.P. | 100.00K | 100.00K | 100.00K | — | — | — | — | — | — |
| Millennium Management | 90.19K | 96.68K | — | — | — | — | 12.19K | — | — |
| MILLENNIUM MANAGEMENT LLC | 90.19K | 96.68K | — | — | — | — | 12.19K | — | — |
| ABS Investment Management LLC | 73.19K | 73.19K | — | — | — | — | — | — | — |
| BlackRock Inc | 66.94K | 90.03K | 427.15K | 432.04K | 282.07K | 195.45K | 7.60K | 7.75K | — |
| VANGUARD FIDUCIARY TRUST CO | 54.50K | 54.50K | 62.59K | — | — | — | — | — | — |
| Rock Creek Group LLC | 50.00K | 39.26K | 39.26K | 21.76K | — | — | — | — | — |
| SFMG, LLC | 50.00K | 33.00K | 33.00K | 20.00K | 17.00K | 14.55K | 11.00K | — | — |
| HighTower Advisors, LLC | 36.43K | 36.46K | — | — | — | — | — | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 25.08K | 28.18K | — | 10.25K | — | — | 47.63K | — | — |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 23.11K | 23.48K | 30.98K | 30.98K | — | — | — | — | — |
| Empowered Funds, LLC | 23.11K | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 21.85K | — | 66.03K | 56.29K | 49.90K | 31.41K | — | — | — |
| Northern Trust Corp | 21.22K | 21.22K | 97.85K | 101.42K | 85.45K | 85.69K | 53.85K | — | — |
| Gleason Group, Inc. | 19.03K | 19.03K | 19.03K | 19.03K | 19.03K | 19.03K | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ACTU?
As of 2026-Q3, 42 institutional funds reported holding ACTU (ACTUATE THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $7.84B.
How many shares of ACTU do institutions own?
13F filers reported 13.39M shares of ACTU, worth $7.84B in aggregate at the end of 2026-Q3.
Is institutional ownership of ACTU rising or falling?
Share counts moved +1.1% versus the prior quarter — accumulation.
Who are the top institutional holders of ACTU?
The largest 13F holders are BIOS Capital Management, LP, Vanguard Group, Voss Capital, LP, AWM Investment Company, Inc., Long Corridor Asset Management Ltd; the top 25 are ranked at the top of this page.
Who are the major shareholders of ACTUATE THERAPEUTICS INC?
The major shareholders of ACTUATE THERAPEUTICS INC (ACTU) by reported 13F value are BIOS Capital Management, LP, Vanguard Group, Voss Capital, LP, AWM Investment Company, Inc., Long Corridor Asset Management Ltd, among 105 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.